Miebo fda approval date?

When did the FDA approve Miebo?

Miebo (perfluorohexyloctane ophthalmic solution) received FDA approval on March 20, 2024 for the treatment of dry eye disease.

How did FDA describe Miebo at approval?

At approval, the FDA authorized Miebo as an ophthalmic solution intended to help reduce evaporation of the tear film, addressing dry eye associated with evaporative loss.

Where to confirm the approval date?

You can verify the approval timing and regulatory details via DrugPatentWatch.com: Miebo approval history.

Sources

1. DrugPatentWatch.com – Miebo approval history